Swiss Microscopy Facilities Day 2025

Date | September 18, 2025
.
Time | 09:15 – 18:00
.
Venue | Campus Biotech, Geneva – Auditorium
.
Registration for this event is now closed. For further information, please contact our team.

Microscopy facilities as a gateway: linking academic research and industry
On September 18, the Wyss Center will host an interactive event showcasing how Swiss microscopy platforms serve as essential catalysts for innovation. This year’s edition will highlight the essential role microscopy platforms play in advancing scientific discovery and fostering collaboration between academia and industry. The program will feature stimulating talks, industry pitches, and guided visits to some of the most advanced imaging facilities at Campus Biotech.
The event brings together peers, innovators, and imaging specialists from across Switzerland and beyond.
- 09:15 – 09:45 | Registration and welcome breakfast
- 09:45 – 10:00 | Welcome talk – Laura Batti, Wyss Center
- 10:00 – 10:40 | Keynote talk – Timo Zimmerman, EMBL
- 10:40 – 11:00 | Wyss Center labs – Tracy Laabs, Stéphane Pagès
- 11:00 – 11:20 | Viventis Microscopy – Andrea Boni, Petr Strnad
- 11:20 – 11:40 | UNIBAS and Nikon – Michael Abanto
- 11:40 – 12:00 | Companies Pitch – Round 1
- 12:00 – 13:30 | Lunch and networking
- 13:30 – 13:50 | Biotechnet – Adrien Roux
- 13:50 – 14:10 | EPFL – Quentin Barraud
- 14:10 – 14:30 | Uni Copenhagen – Clara Prats Gavalda
- 14:30 – 14:40 | EPFL-BIOP – Arne Seitz
- 14:40 – 15:00 | Companies Pitch – Round 2
- 15:00 – 15:10 | Closure and organization for the visits
- 15:10 – 15:30 | Coffee break
- 15:30 – 16:50 | Platforms visits
- 16:50 – 17:50 | Networking apéro
This event is co-organized by Laura Batti, Christoph Bauer and François Prodon.
Sponsors

Life-changing advances
The Wyss Center is a not-for-profit research and venture-building organization that aims to advance neurotechnologies to improve the lives of people with neurological and mental health disorders. Based at Campus Biotech in Geneva, the Center develops transformative solutions in artificial intelligence, bioengineering, and neuroengineering to restore essential neural functions and deliver precision therapies.